To our best knowledge, studies investigating the correlation between BIRC5 and DR5 remain scarce, therefore it would be plausible to suggest that BIRC5/DR5 may be a novel strategy involved in lung adenocarcinoma therapy. The gene discussed is TNFRSF10B; the disease is lung adenocarcinoma.